Physician profile
Ryan Bearer
NPI 1407050842
$34,673.06
in general payments reported to CMS, 2019-2025
32 companies · $903 in 2025
The $903 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $5,686 · 2021: $3,174 · 2022: $2,732 · 2023: $2,454 · 2024: $4,473 · 2025: $903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,943 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,100 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,943.25 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $787.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $23,876.08 | 2019-2024 | Senza |
| Medtronic USA, INC. | $4,281.59 | 2019-2020 | |
| Vertiflex, INC. | $1,950.57 | 2019 | |
| Boston Scientific Corporation | $1,266.76 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Medtronic, INC. | $712.84 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Globus Medical, INC. | $345.18 | 2025 | Senza |
| Abbvie INC. | $247.02 | 2023-2025 | Qulipta |
| Painteq LLC | $234.11 | 2022-2024 | Painteq |
| Vertos Medical, INC. | $208.72 | 2021-2023 | Mild Device Kit |
| Nalu Medical, INC. | $196.50 | 2023-2024 | Nalu Neurostimulation System |
| Curonix LLC | $142.08 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $133.19 | 2023 | Qutenza |
| Stryker Corporation | $130.03 | 2019-2021 | |
| Mml US, INC. | $121.80 | 2023 | Reactiv8 |
| Collegium Pharmaceutical, INC. | $117.59 | 2022-2025 | Belbuca |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $111.23 | 2019-2024 | Eterna |
| Smoky Mountain Surgical LLC | $69.88 | 2023 | |
| Tersera Therapeutics LLC | $68.84 | 2023-2024 | Prialt |
| Saluda Medical Americas, INC. | $62.24 | 2023-2025 | Evoke Scs, Evoke |
| Biotronik Nro, INC. | $60.98 | 2025 | Prospera |
| Spinefrontier, INC. | $58.03 | 2024 | Sijfuse |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.29 | 2022-2025 | Relistor |
| Novartis Pharmaceuticals Corporation | $49.00 | 2019 | |
| Relievant Medsystems, INC. | $39.50 | 2022 | |
| Scilex Pharmaceuticals INC. | $26.82 | 2023 | Ztlido |
| Azurity Pharmaceuticals, INC. | $19.06 | 2024 | Horizant |
| Almatica Pharma LLC | $16.01 | 2022 | |
| Amgen INC. | $15.93 | 2025 | Evenity |
| Radius Health, INC. | $15.14 | 2019 | |
| Spr Therapeutics, INC | $15.02 | 2020 | |
| Sentynl Therapeutics, INC. | $13.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Bearer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.